Tasso, founded in Seattle, focuses on revolutionizing blood-based diagnostics by empowering patients to collect their own samples at home. Their core mission is to make blood sampling safe, simple, and convenient through user-centric technology. Tasso offers digitally-enhanced, virtually painless remote sampling devices that integrate seamlessly with standard lab processes. Their primary market includes decentralized clinical trials and individuals seeking easy, at-home blood collection solutions.
Notable affiliated individuals and investors include prominent figures in the medical and tech industries, though specific names are not provided. Tasso has achieved significant milestones in making clinical-grade blood sampling accessible and convenient, impacting the landscape of decentralized clinical trials and home diagnostics. Their innovative approach has streamlined the process of blood collection, enhancing patient compliance and broadening the scope of remote healthcare services.
